Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9607124.6Aexternal-prioritypatent/GB9607124D0/en
Application filed by IndividualfiledCriticalIndividual
Priority claimed from PCT/US1997/001455external-prioritypatent/WO1997027853A1/fr
Publication of CA2243272A1publicationCriticalpatent/CA2243272A1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Composés qui inhibent la farnésyl-protéine transférase (Ttase) et la farnésylation de la protéine oncogène Ras. La présente invention concerne en outre des compositions chimiothérapeutiques contenant lesdits composés et des procédés permettant d'inhiber la farnésyl-protéine transférase et la farnésylation de la protéine oncogène Ras.
CA 22432721996-01-301997-01-27Inhibiteurs de farnesyl-proteine transferase
AbandonedCA2243272A1
(fr)